Volume 23, Issue 100 (7-2015)                   J Adv Med Biomed Res 2015, 23(100): 45-52 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohseni M, Dadashi K, Heidari A. The Effect of Intraperitoneal Injection of Molybdenum Nanoparticles on Renal Functional Tests in Rat. J Adv Med Biomed Res 2015; 23 (100) :45-52
URL: http://journal.zums.ac.ir/article-1-3266-en.html
1- Dept .of Food and Drug Control, Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran
2- Dept .of Biotechnology and Nanotechnology, Faculty of Medicine, Student Research Committee, Zanjan University of Medical Sciences, Zanjan, Iran
3- Dept .of Genetics and Molecular Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. , heidariazam@yahoo.com
Abstract:   (151521 Views)

Background and Objective: With the industrialization of nanotechnology and increase in application of nanoparticles in modern technology, carrying out research on nanoparticles and their effects on health is necessary. So, this study was aimed to assess acute toxicity of molybdenum nanoparticles on serum biochemical function of kidney in rat.

Materials and Methods: In this experimental study, 24 male rats were randomly divided into four groups of six: a control group and tree treatment groups. The control group received 1 ml distilled water and the treatment groups received intraperitoneal injection of 5, 10 and 15 mg/kg of molybdenum nanoparticles of 10 nm daily for 28 days. After the last dose, blood samples were taken from all groups and levels of Blood Urea Nitrogen (BUN), creatinine, total protein and albumin were measured and then the groups were compared.

Results: The serum levels of BUN and creatinine in the group receiving 15 mg/kg dose decreased significantly compared to the control group (P<0.05). The serum albumin level in the groups receiving 10 and 15 mg/kg doses showed significant decrease compared to the control group (P<0.05). The serum total protein level in the groups receiving 5, 10 and 15 mg/kg doses showed significant decrease compared to the control group (P<0.05).

Conclusion: The results of this study showed that molybdenum nanoparticles of 10 nm at these concentrations decrease creatinine and BUN levels of serum.

Full-Text [PDF 207 kb]   (160360 Downloads)    
Type of Study: Clinical Trials |
Received: 2015/08/23 | Accepted: 2015/08/23 | Published: 2015/08/23

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb